Diagnosis of Iron Deficiency by Artificial Intelligence Analysis of Eye Photography.

Overview

The objective of our work is to predict the value of ferritin from the eye, thus constituting an original, non-invasive diagnostic method of iron deficiency. To be usable in real life, the algorithm must be comparable to the performance of the reference diagnostic test (determination of ferritin), allowing to obtain a sensitivity of about 90% and a specificity > 95%.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 2023

Detailed Description

Currently, the diagnosis of iron deficiency is invasive, as it requires a venous puncture for serum ferritin assay and blood count analysis to diagnose iron deficiency anemia. This dosage is expensive and represents a major brake in the large-scale screening of iron deficiency, especially in developing countries. Most of the clinical signs of iron deficiency (asthenia, cheilitis, glossitis, alopecia, restless legs syndrome) are not very specific and the diagnosis is most often fortuitous or carried out as part of screening in a population at risk. Iron is essential for many functions of the body, including the synthesis of collagen: in case of deficiency, it is produced with an altered and finer structure. In the eyes, the sclera consists of collagen type IV, whose thinning causes the visualization of the choroidal vessels responsible for a characteristic blue tint. A preliminary work carried out by our team made it possible to measure the increase in the amount of blue color in the sclera of deficient patients, objectifying this clinical sign for the first time. From photographs of patients' eyes, we extracted the percentile of blue contained in the pixels of the digital images of the sclera. This work continued with the automation of the recognition of eye structures, especially the sclera. In order to improve the diagnostic performance of this original and non-invasive method, we want to apply deep-learning methods, which have already been proven in several areas: related to ophthalmology but also in a very encouraging way in the non-invasive diagnosis of anemia. The objective of our work is to predict the value of ferritin from the eye, thus constituting an original, non-invasive diagnostic method of iron deficiency. To be usable in real life, the algorithm must be comparable to the performance of the reference diagnostic test (determination of ferritin), allowing to obtain a sensitivity of about 90% and a specificity > 95%.

Interventions

  • Other: photographs of each eye
    • All subjects included will take 5 photographs of each eye according to a standardised procedure in terms of distance, lighting and framing

Clinical Trial Outcome Measures

Primary Measures

  • Validate in a real clinical situation (systematic screening for iron deficiency)
    • Time Frame: evaluation 15 day after diagnostic
    • Validate in a real clinical situation (systematic screening for iron deficiency) a tool for predicting ferritin levels based on digital photographs of the ocular sclera, with confrontation of a learning base treated by deep learning, and a test base

Secondary Measures

  • To study the informational value of photographic data
    • Time Frame: evaluation 15 day after diagnostic
    • To study the informational value of photographic data from the sclera concerning (in pixels) other biological parameters, in particular hemoglobin levels (in g/dl).
  • Identify external factors influencing the quality of the ferritin
    • Time Frame: evaluation 15 day after diagnostic
    • Identify external factors influencing the quality of the ferritin prediction algorithm (in particular, exposure and light polarization, which will be data automatically recorded by the camera allowing shooting, but also phototype according fitzpatrick classification)

Participating in This Clinical Trial

Inclusion Criteria

  • Female sex – Age ≥ 18 years old – Able to express non-opposition to participation in rese – Patients affiliated to a social security scheme – Screenng for iron deficiency within 15 days of inclusion, including – Blood count : value of hemoglobin, mean blood volume – Serum ferritin Exclusion Criteria:

  • Personal history of severe trauma or surgery of both eyes (apart from refractive surgery performed more than 3 months ago) – Personal history of hereditary connective tissue pathology including Marfan's disease, Ehler Danlos syndrome, imperfect osteogenesis. – Personal history of pathology responsible for chronic hemolysis due to yellow coloration induced by hyperbilirubinemia: sickle cell disease, major thalassemia. – Prolonged treatment with minocycline (> 1 month). – Oral or intravenous martial supplementation started more than 15 days prior to taking the sclera photographs. – Person deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision) – Pregnant or breastfeeding woman – Expression of opposition to research.

Gender Eligibility: Female

Female sex

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Clermont-Ferrand
  • Collaborator
    • Université d’Auvergne
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Hervé LOBBES, Principal Investigator, University Hospital, Clermont-Ferrand
  • Overall Contact(s)
    • Lise Laclautre, +33 473 754 963, promo_interne_drci@chu-clermontferrand.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.